Annual CFF:
-$28.35M+$120.37M(+80.94%)Summary
- As of today, CORT annual cash from financing is -$28.35 million, with the most recent change of +$120.37 million (+80.94%) on December 31, 2024.
- During the last 3 years, CORT annual cash from financing has risen by +$274.24 million (+90.63%).
- CORT annual cash from financing is now -131.65% below its all-time high of $89.57 million, reached on December 31, 2012.
Performance
CORT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
-$46.41M+$56.52M(+54.91%)Summary
- As of today, CORT quarterly cash from financing is -$46.41 million, with the most recent change of +$56.52 million (+54.91%) on September 30, 2025.
- Over the past year, CORT quarterly cash from financing has dropped by -$25.32 million (-120.05%).
- CORT quarterly cash from financing is now -161.06% below its all-time high of $76.01 million, reached on September 30, 2012.
Performance
CORT Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$193.71M-$25.32M(-15.04%)Summary
- As of today, CORT TTM cash from financing is -$193.71 million, with the most recent change of -$25.32 million (-15.04%) on September 30, 2025.
- Over the past year, CORT TTM cash from financing has dropped by -$170.69 million (-741.54%).
- CORT TTM cash from financing is now -316.28% below its all-time high of $89.57 million, reached on December 31, 2012.
Performance
CORT TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CORT Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +80.9% | -120.0% | -741.5% |
| 3Y3 Years | +90.6% | -232.4% | +13.6% |
| 5Y5 Years | +1.0% | -891.2% | -1621.6% |
CORT Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -64.0% | +90.6% | -6159.1% | +68.2% | -3215.3% | +13.6% |
| 5Y | 5-Year | -332.1% | +90.6% | -891.2% | +77.6% | -1621.6% | +36.0% |
| All-Time | All-Time | -131.7% | +90.6% | -161.1% | +77.6% | -316.3% | +36.0% |
CORT Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$46.41M(+54.9%) | -$193.71M(-15.0%) |
| Jun 2025 | - | -$102.93M(-158.6%) | -$168.39M(-149.1%) |
| Mar 2025 | - | -$39.80M(-772.1%) | -$67.61M(-138.5%) |
| Dec 2024 | -$28.35M(+80.9%) | -$4.56M(+78.4%) | -$28.35M(-23.2%) |
| Sep 2024 | - | -$21.09M(-881.0%) | -$23.02M(-294.0%) |
| Jun 2024 | - | -$2.15M(-295.9%) | -$5.84M(+96.1%) |
| Mar 2024 | - | -$543.00K(-170.9%) | -$149.45M(-0.5%) |
| Dec 2023 | -$148.72M(-760.5%) | $766.00K(+119.6%) | -$148.72M(+0.6%) |
| Sep 2023 | - | -$3.92M(+97.3%) | -$149.55M(+6.3%) |
| Jun 2023 | - | -$145.75M(>-9900.0%) | -$159.59M(-861.6%) |
| Mar 2023 | - | $181.00K(+396.7%) | -$16.60M(+4.0%) |
| Dec 2022 | -$17.28M(+94.3%) | -$61.00K(+99.6%) | -$17.28M(+92.3%) |
| Sep 2022 | - | -$13.96M(-406.6%) | -$224.19M(+4.1%) |
| Jun 2022 | - | -$2.76M(-444.7%) | -$233.87M(+9.1%) |
| Mar 2022 | - | -$506.00K(+99.8%) | -$257.15M(+15.0%) |
| Dec 2021 | -$302.59M(-2577.4%) | -$206.97M(-775.4%) | -$302.59M(-214.3%) |
| Sep 2021 | - | -$23.64M(+9.2%) | -$96.28M(-44.2%) |
| Jun 2021 | - | -$26.03M(+43.3%) | -$66.77M(-96.8%) |
| Mar 2021 | - | -$45.95M(-6851.1%) | -$33.94M(-377.9%) |
| Dec 2020 | $12.21M(+142.6%) | -$661.00K(-111.3%) | $12.21M(-4.1%) |
| Sep 2020 | - | $5.87M(-13.8%) | $12.73M(+33.2%) |
| Jun 2020 | - | $6.80M(+3219.0%) | $9.56M(+172.7%) |
| Mar 2020 | - | $205.00K(+242.4%) | -$13.15M(+54.1%) |
| Dec 2019 | -$28.64M(-99.8%) | -$144.00K(-105.3%) | -$28.64M(+29.3%) |
| Sep 2019 | - | $2.70M(+116.9%) | -$40.53M(+21.3%) |
| Jun 2019 | - | -$15.91M(-4.0%) | -$51.50M(-63.2%) |
| Mar 2019 | - | -$15.29M(-27.1%) | -$31.55M(-120.1%) |
| Dec 2018 | -$14.34M(-80.2%) | -$12.03M(-45.5%) | -$14.34M(-5550.6%) |
| Sep 2018 | - | -$8.27M(-304.5%) | $263.00K(-96.1%) |
| Jun 2018 | - | $4.04M(+110.4%) | $6.69M(+388.1%) |
| Mar 2018 | - | $1.92M(-25.1%) | -$2.32M(+70.8%) |
| Dec 2017 | -$7.95M(-12.1%) | $2.57M(+239.4%) | -$7.95M(+29.9%) |
| Sep 2017 | - | -$1.84M(+63.0%) | -$11.34M(+7.6%) |
| Jun 2017 | - | -$4.97M(-34.1%) | -$12.27M(-56.6%) |
| Mar 2017 | - | -$3.71M(-350.5%) | -$7.84M(-10.5%) |
| Dec 2016 | -$7.10M(-154.3%) | -$823.00K(+70.3%) | -$7.10M(-13.1%) |
| Sep 2016 | - | -$2.77M(-414.7%) | -$6.27M(-25.8%) |
| Jun 2016 | - | -$538.00K(+81.9%) | -$4.99M(+4.4%) |
| Mar 2016 | - | -$2.97M(-100.3%) | -$5.21M(-142.9%) |
| Dec 2015 | $13.07M(+524.6%) | - | - |
| Sep 2015 | - | -$1.48M(-93.3%) | $12.14M(-1.9%) |
| Jun 2015 | - | -$766.00K(-104.9%) | $12.37M(-1.2%) |
| Mar 2015 | - | $15.52M(+1474.3%) | $12.53M(+506.8%) |
| Dec 2014 | -$3.08M | -$1.13M(+9.6%) | -$3.08M(-21.1%) |
| Sep 2014 | - | -$1.25M(-104.1%) | -$2.54M(-52.1%) |
| Jun 2014 | - | -$612.00K(-587.6%) | -$1.67M(-57.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | -$89.00K(+85.0%) | -$1.06M(-9.2%) |
| Dec 2013 | -$970.00K(-101.1%) | -$592.00K(-56.6%) | -$970.00K(-457.5%) |
| Sep 2013 | - | -$378.00K(>-9900.0%) | -$174.00K(-100.2%) |
| Jun 2013 | - | $0.00(0.0%) | $76.21M(-0.3%) |
| Mar 2013 | - | $0.00(-100.0%) | $76.41M(-14.7%) |
| Dec 2012 | $89.57M(+110.8%) | $204.00K(-99.7%) | $89.57M(+0.2%) |
| Sep 2012 | - | $76.01M(>+9900.0%) | $89.41M(+553.5%) |
| Jun 2012 | - | $198.00K(-98.5%) | $13.68M(-0.3%) |
| Mar 2012 | - | $13.16M(>+9900.0%) | $13.72M(-67.7%) |
| Dec 2011 | $42.48M(+84.7%) | $45.00K(-84.1%) | $42.48M(-2.3%) |
| Sep 2011 | - | $283.00K(+19.9%) | $43.49M(+0.6%) |
| Jun 2011 | - | $236.00K(-99.4%) | $43.23M(-32.8%) |
| Mar 2011 | - | $41.92M(+3865.8%) | $64.35M(+179.8%) |
| Dec 2010 | $23.00M(-2.2%) | $1.06M(+6117.6%) | $23.00M(-41.7%) |
| Sep 2010 | - | $17.00K(-99.9%) | $39.47M(+0.1%) |
| Jun 2010 | - | $21.35M(+3659.5%) | $39.45M(+118.0%) |
| Mar 2010 | - | $568.00K(-96.8%) | $18.09M(-23.1%) |
| Dec 2009 | $23.52M(+21.8%) | $17.53M(>+9900.0%) | $23.52M(+295.2%) |
| Sep 2009 | - | -$3000.00(-50.0%) | $5.95M(-10.3%) |
| Jun 2009 | - | -$2000.00(-100.0%) | $6.64M(+3.4%) |
| Mar 2009 | - | $6.00M(>+9900.0%) | $6.42M(-66.8%) |
| Dec 2008 | $19.32M(+2.4%) | -$41.00K(-106.0%) | $19.32M(-0.2%) |
| Sep 2008 | - | $681.00K(+409.5%) | $19.36M(-32.5%) |
| Jun 2008 | - | -$220.00K(-101.2%) | $28.67M(-0.6%) |
| Mar 2008 | - | $18.90M(>+9900.0%) | $28.86M(+52.9%) |
| Dec 2007 | $18.87M(+536.0%) | $0.00(-100.0%) | $18.87M(-13.5%) |
| Sep 2007 | - | $10.00M(>+9900.0%) | $21.83M(+84.5%) |
| Jun 2007 | - | -$34.00K(-100.4%) | $11.83M(-0.4%) |
| Mar 2007 | - | $8.91M(+201.3%) | $11.88M(+300.2%) |
| Dec 2006 | $2.97M(>+9900.0%) | $2.96M(>+9900.0%) | $2.97M(>+9900.0%) |
| Sep 2006 | - | -$2000.00(-118.2%) | -$24.00K(-284.6%) |
| Jun 2006 | - | $11.00K(+1000.0%) | $13.00K(0.0%) |
| Mar 2006 | - | $1000.00(+102.9%) | $13.00K(+8.3%) |
| Dec 2005 | $12.00K(-100.0%) | -$34.00K(-197.1%) | $12.00K(-89.0%) |
| Sep 2005 | - | $35.00K(+218.2%) | $109.10K(+47.2%) |
| Jun 2005 | - | $11.00K(>+9900.0%) | $74.10K(-99.9%) |
| Mar 2005 | - | $0.00(-100.0%) | $49.45M(+0.7%) |
| Dec 2004 | $49.09M(>+9900.0%) | $63.10K(>+9900.0%) | $49.09M(+0.1%) |
| Sep 2004 | - | $0.00(-100.0%) | $49.03M(0.0%) |
| Jun 2004 | - | $49.39M(>+9900.0%) | $49.03M(>+9900.0%) |
| Mar 2004 | - | -$360.00K(>-9900.0%) | -$322.40K(-957.4%) |
| Dec 2003 | $37.60K(-99.7%) | $300.00(>+9900.0%) | $37.60K(+0.8%) |
| Sep 2003 | - | $0.00(-100.0%) | $37.30K(0.0%) |
| Jun 2003 | - | $37.30K(>+9900.0%) | $37.30K(>+9900.0%) |
| Mar 2003 | - | $0.00 | $0.00 |
| Dec 2002 | $11.80M | - | - |
FAQ
- What is Corcept Therapeutics Incorporated annual cash from financing?
- What is the all-time high annual cash from financing for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual cash from financing year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly cash from financing year-on-year change?
- What is Corcept Therapeutics Incorporated TTM cash from financing?
- What is the all-time high TTM cash from financing for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated TTM cash from financing year-on-year change?
What is Corcept Therapeutics Incorporated annual cash from financing?
The current annual cash from financing of CORT is -$28.35M
What is the all-time high annual cash from financing for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual cash from financing is $89.57M
What is Corcept Therapeutics Incorporated annual cash from financing year-on-year change?
Over the past year, CORT annual cash from financing has changed by +$120.37M (+80.94%)
What is Corcept Therapeutics Incorporated quarterly cash from financing?
The current quarterly cash from financing of CORT is -$46.41M
What is the all-time high quarterly cash from financing for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly cash from financing is $76.01M
What is Corcept Therapeutics Incorporated quarterly cash from financing year-on-year change?
Over the past year, CORT quarterly cash from financing has changed by -$25.32M (-120.05%)
What is Corcept Therapeutics Incorporated TTM cash from financing?
The current TTM cash from financing of CORT is -$193.71M
What is the all-time high TTM cash from financing for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high TTM cash from financing is $89.57M
What is Corcept Therapeutics Incorporated TTM cash from financing year-on-year change?
Over the past year, CORT TTM cash from financing has changed by -$170.69M (-741.54%)